Ligand validation:5K2B

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5K2B designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5K2B_OLC_A_1220	35%	39%	0.134	0.899	1.25	1.13	1	1	0	0	56%	0.56
5K2B_OLC_A_1207	22%	44%	0.162	0.83	1.11	1.06	1	1	2	0	72%	0.72
5K2B_OLC_A_1221	17%	46%	0.186	0.822	1.13	0.98	1	1	0	0	68%	0.68
5K2B_OLC_A_1208	16%	48%	0.159	0.782	1.13	0.9	1	-	0	0	68%	0.68
5K2B_OLC_A_1212	14%	47%	0.183	0.778	1.09	0.95	1	1	0	0	72%	0.72
5K2B_OLC_A_1209	12%	46%	0.252	0.843	1.15	0.93	1	1	0	0	64%	0.64
5K2B_OLC_A_1210	6%	43%	0.256	0.749	1.16	1.05	1	1	0	0	68%	0.68
5K2B_OLC_A_1211	2%	38%	0.306	0.688	1.4	1.06	1	1	0	0	44%	0.44
5K2B_OLC_A_1222	1%	35%	0.284	0.502	1.4	1.19	1	1	0	0	44%	0.44
5K2A_OLC_A_1206	35%	44%	0.134	0.869	1.1	1.05	1	1	0	0	72%	0.72
5K2C_OLC_A_1213	33%	45%	0.149	0.876	1.09	1.03	1	1	1	0	72%	0.72
4EIY_OLC_A_2427	32%	41%	0.143	0.878	1.03	1.24	1	2	0	0	64%	0.64
5K2D_OLC_A_1220	28%	38%	0.181	0.913	1.21	1.2	1	1	0	0	56%	0.56
5VRA_OLC_A_2407	15%	56%	0.274	0.855	0.75	0.96	1	1	3	0	88%	0.88
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.